Anita Brikman: Increasing Awareness of The Ongoing Need for Plasma Donors Is Vital to Ensuring Patient Access and Continuity of Care
Anita Brikman, President and CEO of the Plasma Protein Therapeutics Association (PPTA), shared on LinkedIn:
”During IPAW 2025, I participated in a series of virtual media interviews with television and radio stations around the country to help raise awareness about the essential role of plasma donation and plasma-derived medicines.
I was grateful to be joined by Jana Mattheu, the loving mom of a primary immunodeficiency patient, and by Dr. Michael Keller, a pediatric immunologist at Children’s National Hospital.
Together, we shared how plasma donation plays a critical role in the development of these lifesaving medicines and the science behind these unique therapies.
As Jana shared her family’s emotional and moving story, it was clear to viewers that plasma-derived medicines are not just treatments, they are lifelines.
Her son’s story defines Plasma Powers Possibility – with the help of his IgG infusions, he’s been able to thrive in both school and work.
Increasing awareness of the ongoing need for plasma donors is vital to ensuring patient access and continuity of care.
And we do that by answering questions we often get, many of which we received from members of the media throughout the day:
- How is plasma donation different than blood donation?
- Who does plasma donation help?
- How does someone get started donating?
This is why International Plasma Awareness Week is so important and why awareness, advocacy, and action are carried out year-round by the Plasma Protein Therapeutics Association (PPTA) and its members.
We are also grateful for the continued collaboration of dedicated clinicians, caregivers, and advocates who share this commitment.
Visit to learn more and get involved.”
Stay updated with Hemostasis Today.
-
Oct 9, 2025, 19:53Wilfried Dinh: Top 10 Thrombosis And Antithrombotic Therapy Papers Of 2024
-
Oct 9, 2025, 13:12Abdul Mannan - Ferritin After IV Iron: Timing Matters
-
Oct 9, 2025, 13:11William Aird: Understanding the Ferritin Surge After IV Iron
-
Oct 9, 2025, 13:07World Thrombosis Day: The Silent Threat Of Blood Clots Doesn't Discriminate
-
Oct 9, 2025, 13:01Dr. Abigail Amankwa-Boateng Highlights the Hidden Risk of Venous Thromboembolism in Children
-
Oct 10, 2025, 03:09Giuseppe Lippi: We Show Here That Red Light Therapy Offers Promise in High-Risk Patients
-
Oct 10, 2025, 01:58Emilya Huseynova: Excited to Share That My Work On Blood Safety Monitoring Has Just Been Published by Transfusion
-
Oct 9, 2025, 13:08Superficial Vein Thrombosis: Gregory Piazza Leads JAMA Review Addressing An Underrecognized Challenge
-
Oct 9, 2025, 12:59WFH: Insights From the Prospective Rare Bleeding Disorders Database
-
Oct 9, 2025, 12:58Andrew Jackson: Recurrent Catheter-Related Right Atrial Thrombosis in a Hemodialysis Patient
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 7, 2025, 13:06Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 10, 2025, 03:10Marilena Vrana: Plasma-Derived Medicines Are a Clear Example of Why A One-Size-Fits-All Approach Won’t Work
-
Oct 10, 2025, 03:07Nancy Di Salvo: It's IPAW 2025, How Could I Not Take a Moment to Thank Every Single Plasma Donor Out There?
-
Oct 10, 2025, 03:06Anita Brikman: Increasing Awareness of The Ongoing Need for Plasma Donors Is Vital to Ensuring Patient Access and Continuity of Care
-
Oct 10, 2025, 03:04Stephen Cornelissen: A New Plasma Drop Has Been Added to Lifeblood’s Blood Supply Tracker
-
Oct 10, 2025, 02:12Bethany Samuelson Bannow Welcomed to Department of Hematology and Medical Oncology at the Cancer Institute Cleveland Clinic